Black Pearl Commences Tender Offer for Selectis Health, Inc.
MWN-AI** Summary
On March 11, 2026, Black Pearl Equities, LLC announced a tender offer to acquire up to 100% of the outstanding shares of Selectis Health, Inc. (OTCQB: GBCS) at a price of $5.05 per share in cash. This offer represents a significant 45% premium over the stock's current trading price, and Black Pearl's CEO, Abe Schwartz, emphasized that this move is in the best interest of shareholders, aiming for a collaborative approach with Selectis’s Board of Directors for a successful transaction.
Shareholders wishing to participate must tender their shares by the deadline of May 11, 2026, at 5:00 p.m. EST, unless the offer is extended or terminated earlier. To receive the stated Offer Price, shareholders must follow the specific instructions detailed in the Schedule TO filed with the Securities and Exchange Commission (SEC), which also provides guidance for shareholders with inquiries.
The tender offer is conditional on meeting several criteria, including a minimum tender requirement of 51% of outstanding shares. Additionally, the offer hinges on the absence of any material adverse changes regarding Selectis Health and the fulfillment of standard closing conditions.
As of the announcement, Selectis Health's Board has not issued an official response to the tender offer. Shareholders are encouraged to thoroughly review the SEC filings and can reach out to D.F. King & Co., the appointed Information Agent, for help and additional information.
The press release also includes a disclaimer on forward-looking statements, highlighting potential risks and uncertainties that might impact the transaction's success. Black Pearl Equities has stated that it will not be obligated to update any forward-looking statements unless legally required.
MWN-AI** Analysis
Black Pearl Equities, LLC's commencement of a tender offer to purchase Selectis Health, Inc. shares at $5.05 per share presents a significant opportunity for current shareholders. This offer represents a 45% premium over the recent trading price, highlighting Black Pearl's belief in the inherent value of Selectis Health.
As the tender offer aims to acquire up to 100% of Selectis’ outstanding shares, it’s essential for shareholders to carefully assess their options. The offer has stipulations, including a minimum tender condition requiring 51% of shares to be validly tendered. This could create uncertainty among shareholders about the outcome of the offer, especially if the Selectis Board does not respond favorably. Shareholders should actively monitor the Board's reaction, as any opposition could lead to a more complicated acquisition process.
Investors must weigh the immediate cash offer against long-term potential growth or returns from holding onto their shares. Given the premium offered, many shareholders might find this bid attractive, particularly if they anticipate volatility or underperformance in Selectis Health's business prospects post-offer.
It is also advisable for shareholders to consult with their financial advisors to evaluate the impact of their decisions on their portfolios. They should scrutinize the enclosed documents in the Schedule TO filed with the SEC, as these contain critical information regarding the tender offer's terms and conditions.
Overall, as the expiration date of May 11, 2026, approaches, shareholders should leverage this period to make informed decisions, taking into consideration not just the premium but also the strategic direction of Selectis Health in light of potential future developments and market conditions.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
PR Newswire
BROOKLYN, N.Y., March 11, 2026 /PRNewswire/ -- Black Pearl Equities, LLC has commenced a tender offer to purchase up to 100% of the outstanding shares of Selectis Health, Inc. (OTCQB: GBCS) at $5.05 per share, in cash. The full terms of the offer, including complete instructions and links for shareholders who wish to tender their shares, are contained in the Schedule TO filed today with the Securities and Exchange Commission. Shareholders are encouraged to read it or call (800) 769-4414 for assistance.
"This offer represents a 45% premium to today's trading price. We believe this is in the best interest of shareholders and welcome the opportunity to work constructively with the Board toward a successful outcome. Selectis shareholders are encouraged to tender their shares or contact D.F. King & Co. at (800) 769-4414 to learn how."
— Abe Schwartz, CEO, Black Pearl Equities, LLC
To Shareholders: Please read the Offer to Purchase and related materials filed with the SEC at www.sec.gov before making any decision. Consult your own financial, legal, and tax advisors. The decision is yours to make.
The Tender Offer will expire at 5:00 p.m., New York City time, on May 11, 2026, unless extended (such date and time, as the same may be extended, the "Expiration Time") or earlier terminated. In order to receive the Offer Price, holders and beneficial owners of shares subject to the Tender Offer must validly tender and not validly withdraw their shares on or prior to the Expiration Time, in accordance with the procedures described in the Tender Offer Materials.
The Offer is subject to certain conditions, including, among others, a minimum tender condition requiring that at least 51% of the outstanding shares of Selectis Health be validly tendered and not withdrawn prior to the Expiration Time, the absence of a material adverse change with respect to Selectis Health, and the satisfaction of other customary closing conditions as set forth in the Offer to Purchase. As of the date of this press release, the Board of Directors of Selectis Health has not yet formally responded to the Offer. Shareholders are encouraged to carefully review the Schedule TO and related Offer materials filed with the SEC at www.sec.gov, or to contact the Information Agent at the number below with any questions.
D.F. King & Co., Inc. has been appointed as the Information Agent (the "Information Agent") for the Tender Offer, and Equiniti Trust Company has been appointed as the Depositary (the "Depositary") for the Tender Offer. Questions concerning the Tender Offer may be directed to the Information Agent. You may call the Information Agent via telephone toll free at (800) 769-4414 or (646) 452-2614 outside the U.S. and Canada, or via email at GBCS@dfking.com.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of applicable federal securities laws. All statements other than statements of historical fact are forward-looking statements, including statements regarding Black Pearl Equities' intentions, beliefs, expectations, or projections relating to the proposed acquisition of Selectis Health, Inc. These statements are based on current expectations and assumptions and involve known and unknown risks and uncertainties that may cause actual results, performance, or outcomes to differ materially from those expressed or implied by such statements. Factors that could cause actual results to differ materially include, but are not limited to: the failure of any condition to the Offer to be satisfied or waived, including the 51% minimum tender condition; the failure to obtain any required regulatory, governmental, or third-party consents or approvals; active opposition to the Offer by the Board of Directors or management of Selectis Health, including the adoption of defensive measures or the solicitation of competing offers; litigation or legal proceedings initiated by Selectis Health or its shareholders in connection with the Offer; changes in the business, operations, financial condition, or prospects of Selectis Health prior to or following the expiration of the Offer; adverse developments in general economic, market, or industry conditions; changes in applicable law or regulation; and other risks and uncertainties detailed from time to time in filings with the Securities and Exchange Commission. Nothing in this press release should be construed as a guarantee, representation, or warranty of any kind with respect to the consummation of the proposed transaction or the consideration to be received by shareholders. No forward-looking statement should be relied upon as a representation of future events or outcomes. Black Pearl Equities, LLC expressly disclaims any obligation or undertaking to update, revise, or supplement any forward-looking statement contained herein, whether as a result of new information, future events, changed circumstances, or otherwise, except as required by applicable law.
Black Pearl Equities, LLC | 901 Myrtle Avenue, Brooklyn, NY 11206 | (212) 235-1367 | to@blackpearlequities.com
SOURCE Black Pearl Equities LLC
FAQ**
How does the tender offer price of $5.05 per share for Selectis Health, Inc. (GBCS) compare to its recent trading prices, and what factors are contributing to this significant 45% premium?
What specific conditions must be met for Black Pearl Equities' tender offer for Selectis Health, Inc. (GBCS) to be successful, particularly regarding the minimum tender condition of 51%?
How might the current financial and operational performance of Selectis Health, Inc. (GBCS) impact the likelihood of shareholders accepting the tender offer from Black Pearl Equities?
What potential risks or uncertainties does Black Pearl Equities anticipate that could affect the outcome of the tender offer for Selectis Health, Inc. (GBCS), as mentioned in the press release?
**MWN-AI FAQ is based on asking OpenAI questions about Global Healthcare REIT Inc (OTC: GBCS).
NASDAQ: GBCS
GBCS Trading
0.0% G/L:
$3.95 Last:
1,265 Volume:
$3.95 Open:
